Preferential	O
Enhancement	O
of	O
Sensory	O
and	O
Motor	O
Axon	O
Regeneration	O
by	O
Combining	O
Extracellular	O
Matrix	O
Components	O
with	O
Neurotrophic	B-GP
Factors	I-GP

These	O
authors	O
contributed	O
equally	O
to	O
this	O
work	O
.	O

After	O
peripheral	B-DS
nerve	I-DS
injury	I-DS
,	O
motor	O
and	O
sensory	O
axons	O
are	O
able	O
to	O
regenerate	O
but	O
inaccuracy	O
of	O
target	O
reinnervation	O
leads	O
to	O
poor	O
functional	O
recovery	O
.	O

Extracellular	O
matrix	O
(	O
ECM	O
)	O
components	O
and	O
neurotrophic	B-GP
factors	I-GP
(	O
NTFs	B-GP
)	O
exert	O
their	O
effect	O
on	O
different	O
neuronal	O
populations	O
creating	O
a	O
suitable	O
environment	O
to	O
promote	O
axonal	O
growth	O
.	O

Here	O
,	O
we	O
assessed	O
in	O
vitro	O
and	O
in	O
vivo	O
the	O
selective	O
effects	O
of	O
combining	O
different	O
ECM	O
components	O
with	O
NTFs	B-GP
on	O
motor	O
and	O
sensory	O
axons	O
regeneration	O
and	O
target	O
reinnervation	O
.	O

Organotypic	O
cultures	O
with	O
collagen	B-GP
,	O
laminin	B-GP
and	O
nerve	B-GP
growth	I-GP
factor	I-GP
(	O
NGF	B-GP
)/	O
neurotrophin	B-GP
-	I-GP
3	I-GP
(	O
NT3	B-GP
)	O
or	O
collagen	B-GP
,	O
fibronectin	B-GP
and	O
brain	B-GP
-	I-GP
derived	I-GP
neurotrophic	I-GP
factor	I-GP
(	O
BDNF	B-GP
)	O
selectively	O
enhanced	O
sensory	O
neurite	O
outgrowth	O
of	O
DRG	O
neurons	O
and	O
motor	O
neurite	O
outgrowth	O
from	O
spinal	O
cord	O
slices	O
respectively	O
.	O

For	O
in	O
vivo	O
studies	O
,	O
the	O
rat	B-OG
sciatic	O
nerve	O
was	O
transected	O
and	O
repaired	O
with	O
a	O
silicone	O
tube	O
filled	O
with	O
a	O
collagen	B-GP
and	O
laminin	B-GP
matrix	O
with	O
NGF	B-GP
/	O
NT3	B-GP
encapsulated	O
in	O
poly	O
(	O
lactic	O
-	O
co	O
-	O
glycolic	O
acid	O
)	O
(	O
PLGA	O
)	O
microspheres	O
(	O
MP	O
)	O
(	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
),	O
or	O
a	O
collagen	B-GP
and	O
fibronectin	B-GP
matrix	O
with	O
BDNF	B-GP
in	O
PLGA	O
MPs	O
(	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
).	O

Retrograde	O
labeling	O
and	O
functional	O
tests	O
showed	O
that	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
increased	O
the	O
number	O
of	O
regenerated	O
sensory	O
neurons	O
and	O
improved	O
sensory	O
functional	O
recovery	O
,	O
whereas	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
preferentially	O
increased	O
regenerated	O
motoneurons	O
and	O
enhanced	O
motor	O
functional	O
recovery	O
.	O

Therefore	O
,	O
combination	O
of	O
ECM	O
molecules	O
with	O
NTFs	B-GP
may	O
be	O
a	O
good	O
approach	O
to	O
selectively	O
enhance	O
motor	O
and	O
sensory	O
axons	O
regeneration	O
and	O
promote	O
appropriate	O
target	O
reinnervation	O
.	O

1	O
.	O

Introduction	O

After	O
peripheral	B-DS
nerve	I-DS
injury	I-DS
,	O
transected	O
axons	O
in	O
the	O
distal	O
stump	O
are	O
disconnected	O
from	O
the	O
neuronal	O
body	O
and	O
undergo	O
Wallerian	O
degeneration	O
,	O
thus	O
leading	O
to	O
denervation	O
of	O
peripheral	O
organs	O
[	O
1	O
].	O

Axotomized	O
neurons	O
switch	O
to	O
a	O
growth	O
state	O
,	O
and	O
non	O
-	O
neuronal	O
cells	O
in	O
the	O
distal	O
stump	O
undergo	O
activation	O
and	O
dedifferentiation	O
to	O
sustain	O
nerve	O
regeneration	O
[	O
2	O
,	O
3	O
].	O

Even	O
though	O
axons	O
are	O
able	O
to	O
regenerate	O
after	O
nerve	O
transection	O
,	O
axons	O
grow	O
randomly	O
among	O
the	O
endoneurial	O
tubules	O
in	O
the	O
distal	O
nerve	O
,	O
so	O
that	O
the	O
accuracy	O
of	O
target	O
reinnervation	O
is	O
usually	O
poor	O
,	O
resulting	O
in	O
limited	O
functional	O
recovery	O
[	O
4	O
,	O
5	O
,	O
6	O
,	O
7	O
].	O

Therefore	O
,	O
a	O
pro	O
-	O
regenerative	O
environment	O
that	O
selectively	O
guides	O
motor	O
and	O
sensory	O
axons	O
to	O
regenerate	O
into	O
different	O
branches	O
of	O
the	O
injured	O
nerve	O
may	O
be	O
useful	O
to	O
increase	O
the	O
options	O
of	O
specific	O
target	O
reinnervation	O
.	O

Selective	O
regeneration	O
of	O
different	O
axonal	O
populations	O
would	O
be	O
also	O
useful	O
in	O
the	O
field	O
of	O
neuroprosthetics	O
,	O
as	O
separating	O
motor	O
axons	O
from	O
sensory	O
axons	O
in	O
mixed	O
nerves	O
will	O
functionally	O
improve	O
selective	O
recording	O
and	O
stimulation	O
for	O
providing	O
bidirectional	O
communication	O
with	O
the	O
prosthesis	O
[	O
8	O
,	O
9	O
].	O

After	O
peripheral	B-DS
nerve	I-DS
injury	I-DS
,	O
the	O
generation	O
of	O
a	O
pro	O
-	O
regenerative	O
environment	O
involves	O
the	O
upregulation	O
and	O
secretion	O
of	O
extracellular	O
matrix	O
(	O
ECM	O
)	O
components	O
,	O
such	O
as	O
collagen	B-GP
type	I-GP
IV	I-GP
,	O
laminin	B-GP
and	O
fibronectin	B-GP
,	O
and	O
the	O
secretion	O
of	O
different	O
neurotrophic	B-GP
factors	I-GP
(	O
NTFs	B-GP
),	O
such	O
as	O
nerve	B-GP
growth	I-GP
factor	I-GP
(	O
NGF	B-GP
),	O
brain	B-GP
-	I-GP
derived	I-GP
neurotrophic	I-GP
factor	I-GP
(	O
BDNF	B-GP
),	O
neurotrophin	B-GP
-	I-GP
3	I-GP
(	O
NT3	B-GP
),	O
and	O
glial	B-GP
derived	I-GP
neurotrophic	I-GP
factor	I-GP
(	O
GDNF	B-GP
),	O
among	O
others	O
[	O
10	O
].	O

ECM	O
components	O
interact	O
with	O
integrin	B-GP
heterodimer	I-GP
receptors	I-GP
that	O
are	O
highly	O
expressed	O
in	O
growth	O
cones	O
and	O
non	O
-	O
neuronal	O
cells	O
,	O
both	O
during	O
development	O
and	O
after	O
injury	B-DS
[	O
11	O
,	O
12	O
],	O
promoting	O
axonal	O
guidance	O
,	O
cell	O
adhesion	O
and	O
migration	O
.	O

For	O
instance	O
,	O
laminin	B-GP
substrates	O
enhance	O
elongation	O
of	O
sensory	O
neurites	O
in	O
vitro	O
when	O
compared	O
to	O
collagen	B-GP
or	O
fibronectin	B-GP
containing	O
scaffolds	O
,	O
whereas	O
fibronectin	B-GP
substrates	O
promote	O
neurite	O
elongation	O
of	O
motor	O
neurons	O
from	O
SC	O
slices	O
in	O
vitro	O
[	O
13	O
,	O
14	O
].	O

On	O
the	O
other	O
hand	O
,	O
the	O
interaction	O
between	O
NTFs	B-GP
and	O
their	O
different	O
receptors	O
,	O
such	O
as	O
Trk	B-GP
/	O
p75	B-GP
receptors	O
or	O
GDNFR	B-GP
/	O
RET	B-GP
receptors	O
,	O
promotes	O
survival	O
and	O
axonal	O
regeneration	O
of	O
different	O
neuronal	O
populations	O
.	O

For	O
example	O
,	O
we	O
found	O
that	O
NGF	B-GP
selectively	O
promotes	O
sensory	O
neurite	O
outgrowth	O
,	O
whereas	O
BDNF	B-GP
or	O
fibroblast	B-GP
growth	I-GP
factor	I-GP
(	O
FGF	B-GP
)	O
preferentially	O
increase	O
motor	O
neurite	O
outgrowth	O
in	O
vitro	O
[	O
15	O
].	O

Several	O
reports	O
have	O
demonstrated	O
that	O
the	O
pattern	O
of	O
NTFs	B-GP
expressed	O
in	O
denervated	O
Schwann	O
cells	O
after	O
nerve	B-DS
injury	I-DS
is	O
different	O
between	O
motor	O
and	O
sensory	O
nerve	O
branches	O
,	O
and	O
that	O
motor	O
and	O
sensory	O
axons	O
also	O
express	O
different	O
cell	O
adhesion	O
molecules	O
that	O
may	O
promote	O
differential	O
binding	O
to	O
ECM	O
molecules	O
[	O
16	O
,	O
17	O
,	O
18	O
,	O
19	O
].	O

Manipulation	O
of	O
some	O
of	O
these	O
differential	O
biomarkers	O
may	O
play	O
a	O
role	O
in	O
promoting	O
selective	O
regeneration	O
of	O
different	O
axonal	O
populations	O
and	O
improving	O
subsequent	O
accurate	O
reinnervation	O
.	O

However	O
,	O
the	O
majority	O
of	O
the	O
studies	O
have	O
only	O
investigated	O
the	O
effect	O
of	O
these	O
molecules	O
individually	O
,	O
disregarding	O
the	O
synergistic	O
interactions	O
of	O
ECM	O
molecules	O
with	O
NTFs	B-GP
[	O
20	O
].	O

Therefore	O
,	O
in	O
this	O
study	O
,	O
we	O
tested	O
whether	O
the	O
combination	O
of	O
different	O
NTFs	B-GP
and	O
ECM	O
components	O
,	O
that	O
were	O
previously	O
shown	O
to	O
produce	O
a	O
selective	O
although	O
limited	O
stimulus	O
for	O
either	O
sensory	O
or	O
motor	O
axons	O
regeneration	O
[	O
14	O
,	O
21	O
],	O
was	O
able	O
to	O
produce	O
a	O
synergistic	O
and	O
selective	O
pro	O
-	O
regenerative	O
effect	O
on	O
motor	O
and	O
sensory	O
neurons	O
.	O

Briefly	O
,	O
addition	O
of	O
both	O
LM	B-GP
and	O
NGF	B-GP
/	O
NT3	B-GP
or	O
FN	B-GP
and	O
BDNF	B-GP
increased	O
the	O
amount	O
of	O
sensory	O
and	O
motor	O
neurite	O
outgrowth	O
,	O
respectively	O
,	O
in	O
culture	O
models	O
.	O

Moreover	O
,	O
these	O
effects	O
were	O
maintained	O
in	O
vivo	O
in	O
adult	O
animals	B-OG
as	O
sensory	O
and	O
motor	O
axonal	O
regeneration	O
as	O
well	O
as	O
functional	O
recovery	O
was	O
enhanced	O
after	O
treating	O
nerve	B-DS
injuries	I-DS
with	O
a	O
nerve	O
conduit	O
prefilled	O
with	O
the	O
same	O
combinations	O
of	O
NTFs	B-GP
and	O
ECM	O
components	O
.	O

2	O
.	O

Results	O

2	O
.	O
1	O
.	O

In	O
Vitro	O
Effects	O
of	O
Combining	O
Neurotrophic	B-GP
Factors	I-GP
(	O
NTFs	B-GP
)	O
and	O
Extracellular	O
Matrix	O
(	O
ECM	O
)	O
Substrates	O
on	O
Neurite	O
Outgrowth	O

To	O
study	O
the	O
effect	O
of	O
different	O
combinations	O
of	O
NTFs	B-GP
and	O
ECM	O
components	O
on	O
motor	O
and	O
sensory	O
neurons	O
outgrowth	O
,	O
we	O
first	O
performed	O
an	O
in	O
vitro	O
screening	O
using	O
spinal	O
cord	O
(	O
SC	O
)	O
slices	O
and	O
DRG	O
explants	O
.	O

In	O
cultures	O
of	O
SC	O
slices	O
(	O
Figure	O
1	O
),	O
addition	O
of	O
FN	B-GP
to	O
the	O
matrix	O
doubled	O
the	O
maximum	O
neurite	O
length	O
whereas	O
addition	O
of	O
LM	B-GP
did	O
not	O
increase	O
it	O
compared	O
to	O
the	O
control	O
COL	B-GP
matrix	O
(	O
Figure	O
1J	O
).	O

Addition	O
of	O
BDNF	B-GP
but	O
not	O
of	O
NGF	B-GP
/	O
NT3	B-GP
to	O
the	O
different	O
substrates	O
enhanced	O
neurite	O
length	O
.	O

Furthermore	O
,	O
the	O
combination	O
of	O
FN	B-GP
+	O
BDNF	B-GP
significantly	O
enhanced	O
maximum	O
neurite	O
length	O
and	O
density	O
of	O
neurites	O
compared	O
to	O
the	O
other	O
single	O
and	O
combined	O
groups	O
.	O

Thus	O
,	O
while	O
groups	O
with	O
either	O
FN	B-GP
or	O
BDNF	B-GP
present	O
an	O
increase	O
in	O
the	O
amount	O
and	O
length	O
of	O
neurites	O
,	O
the	O
combination	O
of	O
the	O
two	O
factors	O
shows	O
a	O
synergistic	O
effect	O
with	O
significant	O
differences	O
with	O
respect	O
to	O
all	O
the	O
other	O
groups	O
.	O

On	O
the	O
other	O
hand	O
,	O
LM	B-GP
or	O
NGF	B-GP
/	O
NT3	B-GP
alone	O
or	O
combined	O
did	O
not	O
show	O
any	O
improvement	O
(	O
Figure	O
1J	O
â€“	O
L	O
).	O

In	O
DRG	O
explants	O
(	O
Figure	O
2	O
),	O
addition	O
of	O
LM	B-GP
or	O
FN	B-GP
into	O
the	O
collagen	B-GP
matrix	O
similarly	O
enhanced	O
the	O
maximum	O
neurite	O
length	O
(	O
Figure	O
2J	O
)	O
compared	O
to	O
collagen	B-GP
alone	O
.	O

The	O
addition	O
of	O
NGF	B-GP
/	O
NT3	B-GP
or	O
BDNF	B-GP
into	O
COL	B-GP
,	O
LM	B-GP
and	O
FN	B-GP
substrates	O
enhanced	O
maximum	O
neurite	O
length	O
compared	O
with	O
COL	B-GP
substrate	O
except	O
COL	B-GP
+	O
BDNF	B-GP
cultures	O
.	O

It	O
is	O
noteworthy	O
that	O
only	O
LM	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
group	O
showed	O
differences	O
in	O
maximum	O
neurite	O
length	O
with	O
respect	O
to	O
all	O
the	O
other	O
culture	O
conditions	O
except	O
with	O
LM	B-GP
+	O
BDNF	B-GP
.	O

The	O
addition	O
of	O
NGF	B-GP
and	O
NT3	B-GP
enhanced	O
significantly	O
the	O
density	O
of	O
neurites	O
in	O
all	O
the	O
substrates	O
,	O
being	O
LM	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
the	O
most	O
prominent	O
.	O

In	O
contrast	O
,	O
addition	O
of	O
BDNF	B-GP
only	O
promoted	O
neurite	O
growth	O
with	O
LM	B-GP
but	O
not	O
when	O
combined	O
with	O
COL	B-GP
or	O
FN	B-GP
(	O
Figure	O
2L	O
).	O

These	O
results	O
indicate	O
that	O
combination	O
of	O
FN	B-GP
+	O
BDNF	B-GP
shows	O
synergistic	O
effects	O
on	O
motor	O
neurons	O
promoting	O
neurite	O
elongation	O
and	O
arborization	O
,	O
with	O
weaker	O
effect	O
on	O
sensory	O
elongation	O
,	O
whereas	O
LM	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
is	O
the	O
only	O
condition	O
that	O
exhibits	O
a	O
synergistic	O
effects	O
on	O
sensory	O
but	O
not	O
on	O
motor	O
neurons	O
based	O
on	O
the	O
enhancement	O
observed	O
in	O
neurite	O
elongation	O
and	O
arborization	O
.	O

2	O
.	O
2	O
.	O

In	O
Vivo	O
Effects	O
of	O
Combination	O
of	O
NTF	B-GP
and	O
ECM	O
Substrates	O
on	O
Nerve	O
Regeneration	O

We	O
performed	O
first	O
an	O
in	O
vivo	O
study	O
in	O
which	O
the	O
sciatic	O
nerve	O
was	O
transected	O
and	O
repaired	O
with	O
silicone	O
tubes	O
filled	O
with	O
matrices	O
composed	O
of	O
COL	B-GP
,	O
COL	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
,	O
LM	B-GP
,	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
,	O
COL	B-GP
+	O
MP	O
.	O
BDNF	B-GP
,	O
and	O
FN	B-GP
and	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
to	O
elucidate	O
if	O
the	O
conditions	O
with	O
a	O
more	O
relevant	O
effect	O
in	O
vitro	O
had	O
a	O
similar	O
effect	O
in	O
vivo	O
.	O

The	O
three	O
NTFs	B-GP
(	O
NGF	B-GP
,	O
NT3	B-GP
and	O
BDNF	B-GP
)	O
were	O
encapsulated	O
in	O
PLGA	O
microspheres	O
to	O
allow	O
a	O
sustained	O
release	O
during	O
the	O
time	O
that	O
axons	O
regenerate	O
across	O
the	O
tube	O
[	O
21	O
].	O

All	O
rats	B-OG
showed	O
evidence	O
of	O
axonal	O
regeneration	O
,	O
as	O
judged	O
by	O
the	O
retrograde	O
labeling	O
of	O
motor	O
and	O
sensory	O
neurons	O
with	O
Fluorogold	O
(	O
FG	O
)	O
(	O
Figure	O
3A	O
â€“	O
F	O
).	O

Regarding	O
the	O
number	O
of	O
regenerated	O
motor	O
neurons	O
,	O
all	O
groups	O
with	O
addition	O
of	O
ECM	O
and	O
NTFs	B-GP
showed	O
significant	O
differences	O
with	O
respect	O
to	O
the	O
COL	B-GP
group	O
(	O
p	O
<	O
0	O
.	O
001	O
,	O
Figure	O
3G	O
),	O
being	O
the	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
group	O
the	O
one	O
with	O
the	O
highest	O
effect	O
,	O
that	O
was	O
also	O
significantly	O
higher	O
compared	O
to	O
all	O
other	O
groups	O
except	O
with	O
FN	B-GP
.	O

For	O
sensory	O
neurons	O
,	O
the	O
group	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
showed	O
the	O
highest	O
number	O
of	O
regenerated	O
neurons	O
,	O
and	O
all	O
other	O
groups	O
had	O
better	O
results	O
than	O
the	O
COL	B-GP
control	O
(	O
Figure	O
3H	O
).	O

We	O
then	O
tested	O
whether	O
this	O
preferential	O
effect	O
is	O
maintained	O
in	O
a	O
long	O
term	O
study	O
.	O

For	O
this	O
purpose	O
,	O
we	O
compared	O
groups	O
of	O
rats	B-OG
similar	O
to	O
the	O
short	O
term	O
study	O
but	O
leaving	O
an	O
8	O
mm	O
gap	O
between	O
stumps	O
,	O
since	O
this	O
more	O
challenging	O
gap	O
allows	O
to	O
better	O
elucidate	O
differences	O
between	O
groups	O
[	O
22	O
],	O
and	O
applying	O
the	O
FG	O
retrotracer	O
to	O
the	O
tibial	O
nerve	O
at	O
the	O
ankle	O
at	O
75	O
dpi	O
.	O

In	O
this	O
case	O
,	O
no	O
significant	O
differences	O
in	O
the	O
number	O
of	O
regenerated	O
motor	O
neurons	O
were	O
observed	O
between	O
groups	O
(	O
Figure	O
3I	O
).	O

However	O
,	O
more	O
regenerated	O
sensory	O
neurons	O
were	O
counted	O
in	O
the	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
group	O
compared	O
to	O
the	O
other	O
four	O
groups	O
(	O
Figure	O
3J	O
).	O

Despite	O
the	O
preferential	O
effects	O
observed	O
in	O
vitro	O
appear	O
less	O
marked	O
in	O
vivo	O
,	O
these	O
results	O
indicate	O
that	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
mainly	O
favors	O
motor	O
axon	O
regeneration	O
,	O
whereas	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
is	O
more	O
effective	O
to	O
promote	O
sensory	O
axon	O
regeneration	O
.	O

2	O
.	O
3	O
.	O

Combination	O
of	O
FN	B-GP
and	O
BDNF	B-GP
Promotes	O
Motor	O
Functional	O
Recovery	O
at	O
Long	O
Term	O

We	O
tested	O
if	O
the	O
effects	O
seen	O
on	O
regeneration	O
in	O
the	O
short	O
and	O
long	O
term	O
studies	O
had	O
impact	O
on	O
muscle	O
reinnervation	O
and	O
functional	O
recovery	O
.	O

Nerve	O
conduction	O
tests	O
provided	O
first	O
evidence	O
of	O
reinnervation	O
of	O
the	O
TA	O
muscle	O
at	O
45	O
dpi	O
in	O
all	O
the	O
groups	O
(	O
Figure	O
4A	O
).	O

The	O
amplitude	O
of	O
the	O
CMAP	O
increased	O
during	O
the	O
follow	O
-	O
up	O
.	O

At	O
60	O
dpi	O
,	O
the	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
group	O
showed	O
higher	O
amplitude	O
than	O
all	O
the	O
other	O
groups	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O

FN	B-GP
group	O
also	O
showed	O
significant	O
differences	O
with	O
respect	O
to	O
COL	B-GP
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

However	O
,	O
all	O
groups	O
reached	O
similar	O
CMAP	O
amplitude	O
at	O
75	O
dpi	O
.	O

In	O
the	O
more	O
distal	O
plantar	O
muscles	O
,	O
reinnervation	O
started	O
later	O
compared	O
to	O
TA	O
muscle	O
.	O

In	O
this	O
case	O
,	O
the	O
CMAP	O
amplitude	O
at	O
75	O
dpi	O
was	O
significantly	O
higher	O
in	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
group	O
compared	O
to	O
all	O
the	O
other	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
,	O
Figure	O
4B	O
).	O

No	O
differences	O
in	O
the	O
CMAP	O
latency	O
were	O
observed	O
between	O
groups	O
.	O

These	O
results	O
suggest	O
that	O
an	O
intratubular	O
matrix	O
containing	O
FN	B-GP
and	O
BDNF	B-GP
promotes	O
motor	O
axon	O
regeneration	O
and	O
reinnervation	O
of	O
target	O
muscles	O
,	O
whereas	O
LM	B-GP
and	O
LM	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
groups	O
showed	O
values	O
similar	O
to	O
the	O
COL	B-GP
control	O
group	O
.	O

The	O
faster	O
muscle	O
reinnervation	O
found	O
in	O
group	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
is	O
of	O
relevance	O
considering	O
the	O
longer	O
distance	O
that	O
has	O
to	O
be	O
regenerated	O
in	O
injured	O
human	B-OG
nerves	O
.	O

2	O
.	O
4	O
.	O

Combination	O
of	O
LM	B-GP
and	O
NGF	B-GP
/	O
NT3	B-GP
Promotes	O
Sensory	O
Functional	O
Recovery	O
at	O
Long	O
Term	O

In	O
parallel	O
,	O
we	O
assessed	O
sensory	O
functional	O
recovery	O
to	O
mechanical	O
and	O
thermal	O
stimuli	O
in	O
the	O
hind	O
paw	O
.	O

For	O
the	O
pinprick	O
test	O
,	O
LM	B-GP
and	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
groups	O
presented	O
the	O
first	O
positive	O
response	O
at	O
30	O
dpi	O
,	O
whereas	O
no	O
response	O
was	O
observed	O
in	O
the	O
other	O
groups	O
at	O
this	O
time	O
point	O
.	O

At	O
later	O
time	O
points	O
,	O
all	O
groups	O
showed	O
positive	O
responses	O
,	O
being	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
the	O
only	O
group	O
with	O
significantly	O
higher	O
scores	O
compared	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
;	O
Figure	O
4C	O
).	O

Withdrawal	O
responses	O
to	O
heat	O
stimulation	O
in	O
the	O
plantar	O
test	O
showed	O
similar	O
results	O
to	O
the	O
ones	O
observed	O
for	O
the	O
pinprick	O
.	O

Denervated	O
paws	O
did	O
not	O
respond	O
to	O
the	O
hot	O
stimuli	O
on	O
the	O
lateral	O
region	O
until	O
45	O
dpi	O
and	O
at	O
this	O
time	O
point	O
group	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
showed	O
a	O
shorter	O
latency	O
compared	O
to	O
control	O
,	O
FN	B-GP
and	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
groups	O
(	O
p	O
<	O
0	O
.	O
01	O
;	O
Figure	O
4D	O
),	O
indicating	O
that	O
more	O
sensory	O
fibers	O
arrived	O
to	O
the	O
plantar	O
skin	O
of	O
the	O
paw	O
.	O

However	O
,	O
all	O
groups	O
showed	O
similar	O
latency	O
at	O
60	O
and	O
75	O
dpi	O
.	O

To	O
further	O
corroborate	O
the	O
functional	O
results	O
,	O
skin	O
reinnervation	O
of	O
the	O
lateral	O
paw	O
pads	O
was	O
analyzed	O
by	O
immunohistochemistry	O
.	O

In	O
all	O
the	O
rats	B-OG
PGP	O
immunolabeling	O
showed	O
regenerated	O
nerve	O
fibers	O
that	O
surrounded	O
the	O
SG	O
tubules	O
,	O
reached	O
the	O
subepidermal	O
nerve	O
plexus	O
,	O
and	O
extended	O
to	O
intraepidermal	O
terminals	O
and	O
Meissner	O
corpuscles	O
at	O
the	O
papillae	O
(	O
Figure	O
4E	O
â€“	O
J	O
).	O

Group	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
had	O
significantly	O
higher	O
number	O
of	O
IENF	O
than	O
all	O
the	O
other	O
groups	O
(	O
Figure	O
4K	O
).	O

Similarly	O
,	O
the	O
number	O
of	O
reinnervated	O
SGs	O
was	O
highest	O
in	O
group	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
,	O
although	O
only	O
significantly	O
from	O
groups	O
COL	B-GP
and	O
LM	B-GP
(	O
Figure	O
4L	O
).	O

Taken	O
together	O
,	O
these	O
results	O
indicate	O
that	O
the	O
combination	O
of	O
LM	B-GP
and	O
NGF	B-GP
/	O
NT3	B-GP
enhances	O
sensory	O
axons	O
regeneration	O
and	O
skin	O
reinnervation	O
by	O
populations	O
of	O
sensory	O
neurons	O
that	O
contribute	O
to	O
thermal	O
and	O
mechanical	O
sensibility	O
,	O
and	O
less	O
markedly	O
of	O
sympathetic	O
fibers	O
innervating	O
the	O
SGs	O
.	O

3	O
.	O

Discussion	O

NTFs	B-GP
and	O
ECM	O
components	O
both	O
have	O
important	O
roles	O
in	O
nerve	O
regeneration	O
after	O
injury	B-DS
,	O
including	O
effects	O
on	O
Schwann	O
cell	O
migration	O
and	O
differentiation	O
,	O
neuronal	O
survival	O
,	O
cell	O
adhesion	O
and	O
axonal	O
growth	O
[	O
10	O
,	O
23	O
].	O

To	O
corroborate	O
the	O
preferential	O
effect	O
of	O
NGF	B-GP
,	O
NT	B-GP
-	I-GP
3	I-GP
and	O
LM	B-GP
on	O
sensory	O
neurons	O
and	O
BDNF	B-GP
and	O
FN	B-GP
on	O
motor	O
neurons	O
[	O
15	O
,	O
24	O
,	O
25	O
,	O
26	O
,	O
27	O
],	O
we	O
cultured	O
DRG	O
explants	O
and	O
spinal	O
cord	O
slices	O
.	O

Organotypic	O
cultures	O
are	O
multicellular	O
in	O
vitro	O
models	O
in	O
which	O
neurons	O
and	O
growing	O
neurites	O
share	O
similar	O
differentiation	O
and	O
development	O
patterns	O
with	O
in	O
vivo	O
conditions	O
[	O
28	O
]	O
while	O
they	O
are	O
still	O
in	O
contact	O
with	O
Schwann	O
cells	O
and	O
fibroblasts	O
.	O

In	O
this	O
way	O
,	O
DRG	O
explants	O
have	O
been	O
long	O
used	O
to	O
study	O
axonal	O
growth	O
and	O
regeneration	O
of	O
the	O
sensory	O
nervous	O
system	O
[	O
29	O
,	O
30	O
]	O
as	O
DRG	O
contain	O
the	O
soma	O
of	O
pseudounipolar	O
sensory	O
neurons	O
that	O
project	O
growing	O
neurites	O
outside	O
the	O
ganglion	O
.	O

On	O
the	O
other	O
hand	O
,	O
neurites	O
growing	O
from	O
the	O
ventral	O
areas	O
of	O
the	O
spinal	O
cord	O
arise	O
from	O
motoneurons	O
of	O
the	O
ventral	O
horn	O
instead	O
of	O
other	O
interneurons	O
[	O
31	O
]	O
making	O
this	O
3D	O
culture	O
an	O
useful	O
model	O
for	O
studying	O
regeneration	O
of	O
motor	O
neurites	O
in	O
vitro	O
[	O
32	O
].	O

Taking	O
into	O
account	O
that	O
some	O
NTFs	B-GP
show	O
an	O
attractive	O
or	O
repulsive	O
effect	O
depending	O
on	O
the	O
presence	O
of	O
different	O
ECM	O
molecules	O
[	O
33	O
],	O
we	O
performed	O
a	O
screening	O
of	O
possible	O
combinations	O
added	O
to	O
a	O
collagen	B-GP
gel	O
substrate	O
to	O
investigate	O
if	O
the	O
preferential	O
effects	O
of	O
ECM	O
components	O
and	O
NTFs	B-GP
could	O
be	O
synergistically	O
added	O
in	O
DRG	O
and	O
SC	O
postnatal	O
cultures	O
.	O

We	O
observed	O
an	O
increased	O
effect	O
of	O
LM	B-GP
and	O
NGF	B-GP
+	O
NT3	B-GP
on	O
sensory	O
neurite	O
outgrowth	O
in	O
DRG	O
explants	O
,	O
whereas	O
this	O
combination	O
did	O
not	O
increase	O
motor	O
neurite	O
length	O
.	O

On	O
the	O
other	O
hand	O
,	O
BDNF	B-GP
combined	O
with	O
FN	B-GP
promoted	O
a	O
synergic	O
effect	O
on	O
motor	O
neurite	O
outgrowth	O
with	O
small	O
effects	O
on	O
DRG	O
explants	O
,	O
which	O
can	O
be	O
attributed	O
to	O
the	O
effect	O
on	O
regenerating	O
proprioceptive	O
neurites	O
[	O
14	O
].	O

The	O
synergistic	O
effect	O
can	O
be	O
exemplified	O
for	O
BDNF	B-GP
,	O
that	O
promotes	O
sensory	O
neurite	O
outgrowth	O
in	O
the	O
presence	O
of	O
LM	B-GP
but	O
not	O
when	O
is	O
added	O
alone	O
.	O

These	O
proregenerative	O
effects	O
may	O
be	O
mediated	O
by	O
the	O
differential	O
expression	O
of	O
integrin	O
and	O
NTF	B-GP
receptors	I-GP
in	O
regenerating	O
neurons	O
.	O

It	O
has	O
been	O
described	O
that	O
after	O
injury	B-DS
integrin	B-GP
receptors	I-GP
Î±7Î²1	I-GP
and	O
Î±5Î²1	B-GP
are	O
upregulated	O
in	O
both	O
motor	O
and	O
sensory	O
neurons	O
[	O
14	O
,	O
34	O
],	O
whereas	O
high	O
affinity	O
TrkA	B-GP
and	O
TrkC	B-GP
receptors	O
are	O
expressed	O
in	O
sensory	O
neurons	O
and	O
TrKB	B-GP
is	O
mainly	O
expressed	O
in	O
motoneurons	O
and	O
in	O
a	O
low	O
percentage	O
of	O
sensory	O
neurons	O
[	O
35	O
].	O

It	O
can	O
be	O
hypothesized	O
that	O
the	O
partially	O
selective	O
in	O
vitro	O
effects	O
of	O
NTFs	B-GP
may	O
be	O
enhanced	O
by	O
the	O
presence	O
of	O
certain	O
ECM	O
molecules	O
in	O
the	O
substrate	O
.	O

In	O
fact	O
,	O
it	O
has	O
been	O
reported	O
that	O
the	O
pro	O
-	O
regenerative	O
effects	O
of	O
NGF	B-GP
and	O
NT3	B-GP
are	O
reduced	O
after	O
blocking	O
the	O
Î±7	B-GP
subunit	I-GP
of	I-GP
integrins	I-GP
in	O
sensory	O
neurons	O
[	O
36	O
],	O
and	O
that	O
synergistic	O
actions	O
between	O
integrins	B-GP
and	O
NTF	B-GP
receptors	I-GP
may	O
be	O
attributed	O
to	O
the	O
sustained	O
activation	O
of	O
Src	B-GP
and	O
the	O
downstream	O
signaling	O
Akt	B-GP
intermediate	O
[	O
37	O
].	O

On	O
the	O
other	O
hand	O
,	O
NTFs	B-GP
may	O
also	O
modulate	O
the	O
expression	O
of	O
different	O
integrin	B-GP
receptor	I-GP
subunits	O
,	O
whose	O
upregulation	O
is	O
low	O
in	O
adult	O
compared	O
to	O
their	O
expression	O
in	O
early	O
postnatal	O
animals	B-OG
[	O
38	O
].	O

Actually	O
,	O
NGF	B-GP
contributes	O
to	O
enhance	O
ECM	O
signaling	O
by	O
promoting	O
axonal	O
transport	O
and	O
accumulation	O
of	O
Î²1	B-GP
integrin	I-GP
in	O
growth	O
cones	O
,	O
thus	O
enhancing	O
neurite	O
outgrowth	O
[	O
39	O
].	O

Since	O
the	O
optimal	O
developmental	O
window	O
of	O
regeneration	O
varies	O
from	O
E11	O
â€“	O
E15	O
in	O
the	O
chick	O
spinal	O
cord	O
to	O
P7	O
in	O
rats	B-OG
[	O
40	O
]	O
and	O
the	O
effects	O
of	O
different	O
ECM	O
molecules	O
in	O
vitro	O
are	O
lost	O
when	O
switching	O
from	O
postnatal	O
P7	O
to	O
weaned	O
P21	O
rats	B-OG
[	O
14	O
],	O
it	O
was	O
necessary	O
to	O
confirm	O
in	O
a	O
model	O
of	O
peripheral	B-DS
nerve	I-DS
injury	I-DS
and	O
regeneration	O
in	O
vivo	O
the	O
effects	O
observed	O
in	O
cultures	O
.	O

The	O
in	O
vivo	O
results	O
demonstrated	O
that	O
introduction	O
of	O
a	O
collagen	B-GP
matrix	O
enriched	O
with	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
or	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
within	O
the	O
tube	O
used	O
for	O
nerve	O
repair	O
in	O
adult	O
rats	B-OG
promoted	O
preferential	O
regeneration	O
of	O
sensory	O
and	O
motor	O
axons	O
respectively	O
.	O

The	O
NTFs	B-GP
were	O
encapsulated	O
in	O
PLGA	O
microspheres	O
as	O
they	O
have	O
been	O
approved	O
by	O
the	O
FDA	O
as	O
a	O
drug	O
delivery	O
system	O
[	O
41	O
]	O
and	O
we	O
have	O
recently	O
demonstrated	O
that	O
they	O
do	O
not	O
interfere	O
with	O
axon	O
regeneration	O
and	O
their	O
slow	O
release	O
over	O
more	O
than	O
30	O
days	O
provides	O
more	O
sustained	O
support	O
for	O
nerve	O
regeneration	O
with	O
respect	O
to	O
addition	O
of	O
free	O
NTFs	B-GP
[	O
21	O
].	O

All	O
the	O
treated	O
groups	O
showed	O
an	O
increased	O
number	O
of	O
retrogradely	O
traced	O
motor	O
and	O
sensory	O
neurons	O
that	O
had	O
regenerated	O
their	O
axons	O
to	O
the	O
site	O
of	O
tracer	O
application	O
distal	O
to	O
the	O
tube	O
,	O
compared	O
to	O
the	O
control	O
COL	B-GP
group	O
.	O

This	O
is	O
a	O
positive	O
indication	O
that	O
the	O
design	O
and	O
the	O
concentrations	O
of	O
encapsulated	O
NTFs	B-GP
and	O
ECM	O
components	O
did	O
not	O
cause	O
detrimental	O
effects	O
such	O
as	O
the	O
candy	O
store	O
effect	O
[	O
42	O
]	O
or	O
neuronal	O
death	O
induced	O
by	O
high	O
concentration	O
of	O
NTFs	B-GP
[	O
43	O
].	O

However	O
,	O
the	O
preferential	O
effect	O
mediated	O
by	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
and	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
treatments	O
was	O
more	O
modest	O
compared	O
to	O
the	O
in	O
vitro	O
experiments	O
.	O

This	O
comparative	O
reduction	O
may	O
be	O
explained	O
because	O
of	O
the	O
more	O
complex	O
environment	O
present	O
in	O
the	O
regenerating	O
nerve	O
.	O

After	O
nerve	B-DS
injury	I-DS
,	O
ECM	O
components	O
are	O
synthesized	O
and	O
secreted	O
by	O
non	O
-	O
neuronal	O
cells	O
such	O
as	O
Schwann	O
cells	O
and	O
fibroblasts	O
[	O
44	O
],	O
whereas	O
NTFs	B-GP
are	O
expressed	O
by	O
both	O
neuronal	O
and	O
non	O
-	O
neuronal	O
cells	O
[	O
16	O
,	O
45	O
,	O
46	O
].	O

Furthermore	O
,	O
non	O
-	O
neuronal	O
cells	O
involved	O
in	O
Wallerian	O
degeneration	O
also	O
express	O
integrins	B-GP
and	O
NTF	B-GP
receptors	I-GP
.	O

Therefore	O
,	O
the	O
in	O
vivo	O
implant	O
of	O
a	O
matrix	O
containing	O
ECM	O
components	O
and	O
NTFs	B-GP
in	O
the	O
nerve	O
conduit	O
does	O
not	O
only	O
influence	O
the	O
injured	O
neurons	O
,	O
but	O
also	O
acts	O
on	O
the	O
migrating	O
non	O
-	O
neuronal	O
cells	O
inside	O
the	O
intratubular	O
matrix	O
.	O

Hence	O
,	O
the	O
activation	O
of	O
non	O
-	O
neuronal	O
cells	O
would	O
contribute	O
with	O
proregenerative	O
non	O
-	O
specific	O
cues	O
and	O
decrease	O
the	O
effects	O
of	O
the	O
selective	O
factors	O
introduced	O
in	O
the	O
exogenous	O
matrix	O
.	O

On	O
the	O
other	O
hand	O
,	O
although	O
we	O
still	O
found	O
in	O
vivo	O
a	O
significant	O
preferential	O
regeneration	O
of	O
sensory	O
neurons	O
in	O
animals	B-OG
treated	O
with	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
and	O
of	O
motor	O
neurons	O
in	O
animals	B-OG
treated	O
with	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
,	O
the	O
differences	O
in	O
the	O
amount	O
of	O
regenerated	O
neurons	O
were	O
reduced	O
from	O
the	O
short	O
to	O
the	O
long	O
term	O
study	O
.	O

We	O
can	O
discard	O
that	O
this	O
could	O
be	O
related	O
to	O
an	O
inefficient	O
supply	O
of	O
NTFs	B-GP
as	O
we	O
have	O
previously	O
shown	O
that	O
NTF	B-GP
encapsulation	O
in	O
MPs	O
improved	O
regeneration	O
of	O
both	O
motor	O
and	O
sensory	O
axons	O
,	O
and	O
that	O
PLGA	O
MPs	O
are	O
able	O
to	O
sustain	O
release	O
of	O
these	O
NTFs	B-GP
longer	O
than	O
a	O
month	O
[	O
21	O
].	O

The	O
most	O
plausible	O
explanation	O
for	O
the	O
reduced	O
effect	O
observed	O
would	O
be	O
that	O
most	O
axons	O
had	O
passed	O
the	O
site	O
of	O
tracer	O
application	O
at	O
75	O
dpi	O
,	O
and	O
thus	O
we	O
were	O
not	O
able	O
to	O
detect	O
differences	O
that	O
occurred	O
at	O
earlier	O
time	O
.	O

Although	O
retrolabeling	O
of	O
regenerating	O
neurons	O
is	O
a	O
useful	O
technique	O
to	O
assess	O
the	O
differential	O
effect	O
of	O
local	O
treatments	O
,	O
functional	O
restitution	O
is	O
the	O
most	O
important	O
outcome	O
after	O
nerve	B-DS
injury	I-DS
[	O
47	O
].	O

Thus	O
,	O
in	O
the	O
long	O
term	O
in	O
vivo	O
study	O
we	O
evaluated	O
functional	O
recovery	O
of	O
both	O
motor	O
and	O
sensory	O
targets	O
.	O

Electrophysiological	O
results	O
demonstrated	O
that	O
muscle	O
reinnervation	O
started	O
earlier	O
and	O
achieved	O
higher	O
levels	O
in	O
the	O
FN	B-GP
+	O
MP	O
.	O
BDNF	B-GP
group	O
than	O
in	O
all	O
the	O
other	O
groups	O
.	O

An	O
increased	O
regeneration	O
rate	O
improves	O
muscle	O
reinnervation	O
,	O
particularly	O
of	O
distal	O
muscles	O
in	O
the	O
limb	O
,	O
as	O
shown	O
in	O
the	O
foot	O
muscles	O
in	O
this	O
study	O
,	O
reducing	O
the	O
detrimental	O
consequences	O
of	O
chronic	O
denervation	O
[	O
48	O
].	O

On	O
the	O
other	O
hand	O
,	O
treatment	O
with	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
showed	O
earlier	O
sensory	O
responses	O
to	O
both	O
mechanical	O
and	O
thermal	O
stimuli	O
,	O
confirming	O
the	O
results	O
seen	O
in	O
the	O
retrotracer	O
study	O
.	O

We	O
also	O
demonstrated	O
an	O
increased	O
number	O
of	O
sensory	O
axons	O
reinnervating	O
the	O
epidermis	O
and	O
of	O
sympathetic	O
axons	O
reinnervating	O
the	O
SGs	O
in	O
the	O
skin	O
in	O
the	O
LM	B-GP
+	O
MP	O
.	O
NGF	B-GP
/	O
NT3	B-GP
group	O
.	O

This	O
parallel	O
effect	O
could	O
be	O
explained	O
by	O
the	O
proregenerative	O
role	O
of	O
NGF	B-GP
on	O
sensory	O
as	O
well	O
as	O
on	O
sympathetic	O
neurons	O
[	O
49	O
].	O

4	O
.	O

Materials	O
and	O
Methods	O

4	O
.	O
1	O
.	O

Ethics	O
Statement	O

In	O
vitro	O
(	O
procedure	O
#	O
1963M	O
)	O
and	O
in	O
vivo	O
(	O
procedure	O
#	O
1162MM	O
)	O
experimental	O
procedures	O
were	O
approved	O
in	O
30	O
June	O
2015	O
and	O
in	O
29	O
May	O
2015	O
respectively	O
by	O
the	O
animal	O
and	O
human	B-OG
experimentation	O
ethics	O
committee	O
(	O
CEEAH	O
)	O
of	O
the	O
Universitat	O
Autonoma	O
de	O
Barcelona	O
in	O
accordance	O
with	O
the	O
European	O
Communities	O
Council	O
Directive	O
2010	O
/	O
63	O
/	O
EU	O
.	O

4	O
.	O
2	O
.	O

In	O
Vitro	O
Study	O
on	O
Organotypic	O
Cultures	O

Organotypic	O
cultures	O
were	O
prepared	O
as	O
previously	O
described	O
in	O
detail	O
[	O
32	O
].	O

Briefly	O
,	O
a	O
3	O
mg	O
/	O
mL	O
collagen	B-GP
solution	O
was	O
prepared	O
by	O
mixing	O
rat	B-OG
tail	O
collagen	B-GP
type	I-GP
I	I-GP
(#	O
354236	O
,	O
Corning	O
,	O
Wiesbaden	O
,	O
Germany	O
)	O
with	O
PBS	O
(	O
D8537	O
,	O
Sigma	O
,	O
Tres	O
Cantos	O
,	O
Spain	O
)	O
and	O
sodium	O
bicarbonate	O
at	O
0	O
.	O
3	O
mg	O
/	O
mL	O
,	O
and	O
diluting	O
1	O
:	O
10	O
with	O
basal	O
Eagle	O
â€™	O
s	O
medium	O
(	O
10	O
Ã—,	O
Gibco	O
,	O
Grand	O
Island	O
,	O
NY	O
,	O
USA	O
).	O

NTF	B-GP
enriched	O
substrates	O
were	O
prepared	O
by	O
adding	O
BDNF	B-GP
at	O
50	O
ng	O
/	O
mL	O
(	O
Peprotech	O
,	O
London	O
,	O
UK	O
)	O
or	O
NGF	B-GP
and	O
NT3	B-GP
(	O
Peprotech	O
)	O
at	O
25	O
ng	O
/	O
mL	O
each	O
,	O
and	O
fibronectin	B-GP
(	O
BD	O
Bioscences	O
,	O
Vienna	O
,	O
Austria	O
)	O
or	O
laminin	B-GP
type	I-GP
I	I-GP
(	O
Sigma	O
)	O
to	O
a	O
20	O
%	O
final	O
volume	O
.	O

Single	O
30	O
ÂµL	O
drops	O
of	O
the	O
prepared	O
matrices	O
were	O
deposited	O
on	O
poly	O
-	O
d	O
-	O
lysine	O
(	O
Sigma	O
)	O
coated	O
coverslips	O
,	O
which	O
were	O
placed	O
in	O
Petri	O
dishes	O
or	O
24	O
-	O
well	O
multidishes	O
(	O
Iwaki	O
,	O
Asahi	O
Technoglass	O
,	O
Chiba	O
,	O
Japan	O
),	O
and	O
kept	O
in	O
the	O
incubator	O
at	O
37	O
Â°	O
C	O
and	O
5	O
%	O
CO2	O
for	O
two	O
hours	O
to	O
induce	O
collagen	B-GP
gel	O
formation	O
.	O

Collagen	B-GP
gel	O
was	O
mixed	O
with	O
PBS	O
(	O
COL	B-GP
)	O
and	O
used	O
as	O
control	O
.	O

Collagen	B-GP
gels	O
were	O
also	O
combined	O
with	O
NGF	B-GP
/	O
NT3	B-GP
(	O
COL	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
)	O
or	O
BDNF	B-GP
(	O
COL	B-GP
+	O
BDNF	B-GP
).	O

Similarly	O
,	O
laminin	B-GP
and	O
fibronectin	B-GP
-	O
enriched	O
gels	O
were	O
combined	O
with	O
PBS	O
(	O
LM	B-GP
and	O
FN	B-GP
,	O
respectively	O
),	O
NGF	B-GP
+	O
NT3	B-GP
(	O
LM	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
and	O
FN	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
,	O
respectively	O
)	O
or	O
BDNF	B-GP
(	O
LM	B-GP
+	O
BDNF	B-GP
and	O
FN	B-GP
+	O
BDNF	B-GP
,	O
respectively	O
)	O
(	O
see	O
Table	O
1	O
).	O

The	O
lumbar	O
spinal	O
cord	O
(	O
SC	O
,	O
n	O
=	O
6	O
â€“	O
8	O
/	O
group	O
)	O
and	O
dorsal	O
root	O
ganglia	O
(	O
DRG	O
,	O
n	O
=	O
7	O
â€“	O
8	O
/	O
group	O
)	O
were	O
harvested	O
from	O
7	O
-	O
day	O
-	O
old	O
Sprague	O
-	O
Dawley	O
rats	B-OG
,	O
placed	O
in	O
cold	O
Gey	O
â€™	O
s	O
balanced	O
salt	O
solution	O
(	O
Sigma	O
)	O
enriched	O
with	O
6	O
mg	O
/	O
mL	O
glucose	O
and	O
cleaned	O
.	O

SC	O
350	O
Âµm	O
thick	O
slices	O
and	O
DRG	O
explants	O
were	O
placed	O
on	O
gelled	O
collagen	B-GP
droplets	O
,	O
prepared	O
as	O
indicated	O
above	O
,	O
and	O
covered	O
with	O
a	O
second	O
30	O
ÂµL	O
drop	O
.	O

The	O
embedded	O
samples	O
were	O
placed	O
in	O
the	O
incubator	O
for	O
45	O
min	O
before	O
adding	O
Neurobasal	O
medium	O
(	O
NB	O
,	O
Life	O
Technologies	O
,	O
Carlsbad	O
,	O
CA	O
,	O
USA	O
),	O
supplemented	O
with	O
B27	O
(	O
Life	O
Technologies	O
),	O
glutamine	O
and	O
penicillin	O
/	O
streptomycin	O
(	O
Sigma	O
).	O

SC	O
slices	O
were	O
cultured	O
for	O
4	O
days	O
,	O
and	O
DRG	O
explants	O
for	O
2	O
days	O
.	O

Then	O
,	O
cultures	O
were	O
fixed	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
for	O
30	O
min	O
,	O
and	O
incubated	O
for	O
48	O
h	O
with	O
primary	O
antibody	O
mouse	B-OG
RT97	O
(	O
1	O
:	O
200	O
,	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
,	O
Iowa	O
City	O
,	O
IA	O
,	O
USA	O
)	O
at	O
4	O
Â°	O
C	O
.	O

After	O
washes	O
,	O
the	O
sections	O
were	O
incubated	O
with	O
secondary	O
antibody	O
AF594	O
conjugated	O
donkey	B-OG
anti	O
-	O
mouse	B-OG
(	O
1	O
:	O
200	O
,	O
Life	O
Technologies	O
)	O
overnight	O
at	O
4	O
Â°	O
C	O
.	O

For	O
DRG	O
and	O
SC	O
visualization	O
,	O
samples	O
were	O
mounted	O
on	O
slides	O
using	O
Mowiol	O
with	O
DAPI	O
(	O
100	O
ng	O
/	O
mL	O
,	O
Sigma	O
)	O
for	O
nuclear	O
staining	O
.	O

Olympus	O
BX51	O
fluorescence	O
microscope	O
(	O
Olympus	O
,	O
Hamburg	O
,	O
Germany	O
)	O
attached	O
to	O
a	O
DP73	O
camera	O
was	O
used	O
to	O
obtain	O
images	O
of	O
different	O
areas	O
using	O
cellSens	O
Entry	O
software	O
(	O
version	O
1	O
.	O
12	O
,	O
Olympus	O
),	O
different	O
parts	O
of	O
each	O
sample	O
were	O
merged	O
using	O
Adobe	O
Photoshop	O
CS3	O
(	O
Adobe	O
System	O
,	O
San	O
Jose	O
,	O
CA	O
,	O
USA	O
).	O

To	O
analyze	O
the	O
length	O
of	O
neurites	O
,	O
ImageJ	O
software	O
(	O
NIH	O
,	O
available	O
on	O
:	O
http	O
://	O
rsb	O
.	O
info	O
.	O
nih	O
.	O
gov	O
/	O
ij	O
/)	O
resolution	O
parameters	O
were	O
fixed	O
and	O
the	O
three	O
longest	O
neurites	O
were	O
followed	O
from	O
the	O
ventral	O
horn	O
(	O
spinal	O
cord	O
)	O
or	O
ganglion	O
boundary	O
(	O
DRG	O
)	O
to	O
their	O
ending	O
projections	O
.	O

Whole	O
culture	O
images	O
of	O
the	O
DRG	O
and	O
the	O
ventral	O
horn	O
of	O
the	O
SC	O
were	O
analyzed	O
with	O
the	O
Neurite	O
-	O
J	O
plug	O
-	O
in	O
[	O
50	O
]	O
for	O
ImageJ	O
software	O
,	O
and	O
the	O
number	O
of	O
neurites	O
grown	O
at	O
different	O
distances	O
from	O
the	O
explant	O
was	O
compared	O
between	O
sets	O
of	O
cultures	O
.	O

To	O
facilitate	O
the	O
visualization	O
of	O
differences	O
between	O
groups	O
,	O
the	O
area	O
under	O
the	O
curve	O
of	O
each	O
group	O
was	O
converted	O
to	O
a	O
bar	O
plot	O
.	O

4	O
.	O
3	O
.	O

In	O
Vivo	O
Study	O
of	O
Peripheral	O
Nerve	O
Regeneration	O

Female	O
Sprague	O
-	O
Dawley	O
rats	B-OG
weighing	O
between	O
250	O
â€“	O
300	O
g	O
were	O
used	O
.	O

Animals	B-OG
had	O
ad	O
libitum	O
access	O
to	O
food	O
and	O
water	O
and	O
were	O
kept	O
under	O
a	O
standard	O
light	O
-	O
dark	O
cycle	O
of	O
12	O
:	O
12	O
h	O
.	O

All	O
efforts	O
were	O
made	O
to	O
minimize	O
pain	O
and	O
animal	O
distress	O
during	O
surgery	O
.	O

Rats	B-OG
were	O
anaesthetized	O
with	O
ketamine	O
/	O
xylacine	O
(	O
90	O
/	O
10	O
mg	O
/	O
kg	O
i	O
.	O
p	O
.),	O
the	O
sciatic	O
nerve	O
was	O
exposed	O
at	O
the	O
midthigh	O
and	O
sectioned	O
90	O
mm	O
from	O
the	O
tip	O
of	O
the	O
third	O
toe	O
,	O
and	O
a	O
nerve	O
portion	O
resected	O
.	O

A	O
silicone	O
tube	O
was	O
then	O
sutured	O
with	O
10	O
-	O
0	O
monofilament	O
sutures	O
to	O
each	O
nerve	O
stump	O
leaving	O
a	O
6	O
mm	O
gap	O
between	O
both	O
nerve	O
ends	O
for	O
the	O
short	O
term	O
study	O
or	O
8	O
mm	O
gap	O
for	O
the	O
long	O
term	O
study	O
.	O

Animals	B-OG
were	O
kept	O
for	O
20	O
days	O
post	O
-	O
injury	B-DS
(	O
dpi	O
)	O
(	O
short	O
term	O
)	O
or	O
75	O
dpi	O
(	O
long	O
term	O
)	O
to	O
allow	O
axonal	O
regeneration	O
before	O
testing	O
.	O

Each	O
of	O
the	O
three	O
NTFs	B-GP
(	O
NGF	B-GP
,	O
NT3	B-GP
,	O
and	O
BDNF	B-GP
)	O
were	O
encapsulated	O
in	O
microspheres	O
as	O
previously	O
described	O
[	O
51	O
]	O
and	O
added	O
to	O
a	O
collagen	B-GP
solution	O
to	O
reach	O
a	O
final	O
concentration	O
of	O
2	O
Âµg	O
/	O
mL	O
for	O
BDNF	B-GP
and	O
1	O
Âµg	O
/	O
mL	O
for	O
NGF	B-GP
and	O
NT3	B-GP
respectively	O
.	O

Each	O
preparation	O
of	O
NTF	B-GP
was	O
then	O
added	O
to	O
ECM	O
solutions	O
prepared	O
as	O
for	O
the	O
cultures	O
,	O
i	O
.	O
e	O
.,	O
collagen	B-GP
at	O
3	O
mg	O
/	O
mL	O
,	O
collagen	B-GP
supplemented	O
with	O
laminin	B-GP
20	O
%	O
(	O
v	O
/	O
v	O
),	O
and	O
collagen	B-GP
supplemented	O
with	O
fibronectin	B-GP
20	O
%	O
(	O
v	O
/	O
v	O
).	O

Silicone	O
tubes	O
8	O
or	O
10	O
mm	O
long	O
with	O
an	O
internal	O
diameter	O
of	O
2	O
mm	O
were	O
filled	O
with	O
one	O
of	O
the	O
mixtures	O
containing	O
different	O
combinations	O
of	O
ECM	O
substrates	O
and	O
encapsulated	O
NTF	B-GP
.	O

In	O
order	O
to	O
promote	O
fibril	O
alignment	O
,	O
the	O
collagen	B-GP
solution	O
was	O
left	O
to	O
gel	O
vertically	O
for	O
12	O
h	O
before	O
surgery	O
[	O
52	O
].	O

Therefore	O
,	O
there	O
were	O
7	O
experimental	O
groups	O
for	O
short	O
and	O
5	O
for	O
long	O
term	O
experiments	O
(	O
n	O
=	O
6	O
per	O
group	O
,	O
see	O
Table	O
1	O
).	O

4	O
.	O
4	O
.	O

Retrograde	O
Labeling	O
and	O
Neuronal	O
Counting	O

To	O
quantify	O
motor	O
and	O
sensory	O
regenerated	O
neurons	O
at	O
short	O
term	O
(	O
20	O
dpi	O
),	O
rats	B-OG
were	O
anaesthetized	O
with	O
ketamine	O
/	O
xylacine	O
and	O
the	O
sciatic	O
nerve	O
was	O
exposed	O
and	O
transected	O
8	O
mm	O
distal	O
to	O
the	O
distal	O
end	O
of	O
the	O
silicone	O
tube	O
to	O
apply	O
Fluorogold	O
(	O
FG	O
;	O
5	O
%;	O
Fluorochrome	O
Inc	O
.,	O
Denver	O
,	O
CO	O
,	O
USA	O
)	O
as	O
a	O
retrotracer	O
[	O
53	O
].	O

Briefly	O
,	O
5	O
ÂµL	O
of	O
FG	O
were	O
applied	O
to	O
the	O
end	O
of	O
the	O
nerve	O
for	O
1	O
h	O
,	O
then	O
the	O
retrotracer	O
was	O
washed	O
with	O
saline	O
to	O
remove	O
any	O
residues	O
of	O
the	O
tracer	O
and	O
the	O
wound	O
sutured	O
in	O
planes	O
.	O

Similarly	O
,	O
for	O
the	O
long	O
term	O
study	O
(	O
75	O
dpi	O
)	O
FG	O
was	O
also	O
applied	O
to	O
the	O
tibial	O
nerve	O
at	O
the	O
ankle	O
level	O
.	O

After	O
tracer	O
application	O
,	O
the	O
rats	B-OG
were	O
allowed	O
to	O
survive	O
for	O
7	O
days	O
,	O
then	O
,	O
they	O
were	O
deeply	O
anesthetized	O
and	O
transcardially	O
perfused	O
with	O
4	O
%	O
paraformaldehyde	O
in	O
PBS	O
.	O

The	O
lumbar	O
segment	O
(	O
L3	O
â€“	O
L6	O
)	O
of	O
the	O
SC	O
and	O
the	O
L4	O
and	O
L5	O
DRG	O
were	O
removed	O
,	O
postfixed	O
at	O
4	O
Â°	O
C	O
for	O
1	O
h	O
and	O
transferred	O
to	O
30	O
%	O
sucrose	O
in	O
PBS	O
.	O

Samples	O
were	O
cut	O
in	O
a	O
cryostat	O
longitudinally	O
in	O
40	O
and	O
20	O
Âµm	O
thick	O
sections	O
respectively	O
,	O
mounted	O
s	O
severed	O
he	O
tube	O
on	O
slides	O
,	O
heated	O
at	O
35	O
Â°	O
C	O
for	O
1	O
h	O
and	O
stored	O
at	O
âˆ’	O
20	O
Â°	O
C	O
in	O
the	O
dark	O
.	O

DRG	O
and	O
SC	O
sections	O
were	O
observed	O
with	O
an	O
Olympus	O
BX51	O
fluorescence	O
microscope	O
and	O
the	O
fractionator	O
principle	O
[	O
54	O
]	O
was	O
used	O
to	O
quantify	O
the	O
number	O
of	O
labeled	O
neurons	O
.	O

4	O
.	O
5	O
.	O

Assessment	O
of	O
Muscle	O
Reinnervation	O

Functional	O
reinnervation	O
of	O
target	O
muscles	O
was	O
assessed	O
at	O
7	O
,	O
30	O
,	O
45	O
,	O
60	O
and	O
75	O
dpi	O
by	O
means	O
of	O
nerve	O
conduction	O
tests	O
.	O

Animals	B-OG
were	O
anesthetized	O
with	O
ketamine	O
/	O
xylacine	O
and	O
the	O
sciatic	O
nerve	O
was	O
stimulated	O
by	O
transcutaneous	O
electrodes	O
placed	O
at	O
the	O
sciatic	O
notch	O
.	O

The	O
amplitudes	O
(	O
M	O
wave	O
)	O
of	O
the	O
compound	O
muscle	O
action	O
potentials	O
(	O
CMAP	O
)	O
of	O
tibialis	O
anterior	O
(	O
TA	O
)	O
and	O
plantar	O
interossei	O
muscles	O
(	O
PL	O
)	O
were	O
recorded	O
(	O
mV	O
)	O
after	O
placing	O
monopolar	O
needle	O
electrodes	O
in	O
the	O
muscle	O
bellies	O
and	O
the	O
reference	O
in	O
the	O
fourth	O
toe	O
[	O
55	O
].	O

Values	O
of	O
the	O
contralateral	O
intact	O
limb	O
were	O
used	O
as	O
control	O
.	O

During	O
the	O
tests	O
,	O
the	O
rat	B-OG
body	O
temperature	O
was	O
maintained	O
by	O
means	O
of	O
a	O
thermostated	O
warming	O
flat	O
coil	O
.	O

Animals	B-OG
were	O
anesthetized	O
with	O
ketamine	O
/	O
xylacine	O
and	O
the	O
sciatic	O
nerve	O
was	O
stimulated	O
by	O
transcutaneous	O
electrodes	O
placed	O
at	O
the	O
sciatic	O
notch	O
.	O

4	O
.	O
6	O
.	O

Assessment	O
of	O
Skin	O
Nociceptive	O
Reinnervation	O

The	O
progression	O
of	O
nociceptive	O
reinnervation	O
of	O
the	O
hind	O
paw	O
was	O
assessed	O
by	O
means	O
of	O
the	O
pinprick	O
test	O
and	O
thermal	O
sensitivity	O
at	O
7	O
,	O
30	O
,	O
45	O
,	O
60	O
and	O
75	O
dpi	O
.	O

For	O
the	O
pinprick	O
test	O
,	O
animals	B-OG
were	O
gently	O
kept	O
in	O
a	O
cloth	O
with	O
the	O
sole	O
of	O
the	O
injured	O
paw	O
facing	O
upward	O
,	O
and	O
the	O
skin	O
was	O
stimulated	O
with	O
a	O
needle	O
progressively	O
from	O
proximal	O
to	O
distal	O
at	O
specific	O
sites	O
of	O
the	O
lateral	O
side	O
of	O
the	O
hind	O
paw	O
plantar	O
surface	O
[	O
56	O
].	O

Fast	O
withdrawal	O
of	O
the	O
hindpaw	O
after	O
stimulation	O
was	O
identified	O
as	O
a	O
clear	O
pain	O
reaction	O
and	O
thus	O
a	O
sign	O
of	O
functional	O
skin	O
reinnervation	O
.	O

The	O
mean	O
number	O
of	O
positive	O
responses	O
in	O
every	O
tested	O
area	O
was	O
calculated	O
per	O
group	O
at	O
each	O
day	O
of	O
testing	O
.	O

Thermal	O
sensitivity	O
was	O
evaluated	O
using	O
a	O
Plantar	O
test	O
algesimeter	O
(	O
Ugo	O
Basile	O
,	O
Comerio	O
,	O
Italy	O
)	O
[	O
57	O
].	O

Rats	B-OG
were	O
individually	O
placed	O
in	O
Plexiglas	O
cubicles	O
(	O
20	O
Ã—	O
20	O
Ã—	O
14	O
(	O
h	O
)	O
cm	O
)	O
with	O
an	O
elevated	O
Plexiglas	O
floor	O
in	O
a	O
room	O
at	O
constant	O
temperature	O
(	O
24	O
Â±	O
0	O
.	O
5	O
Â°	O
C	O
).	O

The	O
beam	O
of	O
a	O
low	O
intensity	O
lamp	O
(	O
40	O
mW	O
/	O
cm2	O
)	O
was	O
pointed	O
to	O
the	O
lateral	O
part	O
in	O
the	O
hind	O
paw	O
plantar	O
surface	O
with	O
a	O
heating	O
rate	O
of	O
1	O
Â°	O
C	O
/	O
s	O
to	O
elicit	O
activation	O
of	O
unmyelinated	O
C	O
fibers	O
.	O

A	O
cutoff	O
time	O
of	O
exposure	O
to	O
limit	O
possible	O
tissue	O
damage	O
was	O
set	O
at	O
20	O
s	O
.	O

The	O
latency	O
(	O
in	O
seconds	O
)	O
of	O
hindpaw	O
withdrawal	O
from	O
the	O
thermal	O
stimulus	O
was	O
recorded	O
as	O
the	O
mean	O
of	O
3	O
tests	O
per	O
paw	O
.	O

A	O
5	O
-	O
min	O
resting	O
period	O
was	O
set	O
between	O
each	O
trial	O
.	O

4	O
.	O
7	O
.	O

Evaluation	O
of	O
Skin	O
and	O
Sweat	O
Gland	O
Reinnervation	O

For	O
assessing	O
skin	O
reinnervation	O
,	O
plantar	O
pads	O
corresponding	O
to	O
the	O
lateral	O
side	O
were	O
removed	O
at	O
the	O
end	O
of	O
the	O
functional	O
follow	O
-	O
up	O
.	O

Cryotome	O
sections	O
60	O
Âµm	O
thick	O
were	O
processed	O
for	O
immunolabeling	O
against	O
protein	B-GP
gene	I-GP
product	I-GP
(	I-GP
PGP	I-GP
)	I-GP
9	I-GP
.	I-GP
5	I-GP
(	O
rabbit	B-OG
;	O
1	O
:	O
1000	O
;	O
UltraClone	O
,	O
Cambridge	O
,	O
UK	O
),	O
a	O
pan	O
-	O
neuronal	O
marker	O
.	O

Secondary	O
antibodies	O
were	O
conjugated	O
to	O
Cy3	O
.	O

Sections	O
were	O
observed	O
with	O
an	O
Olympus	O
BX51	O
fluorescence	O
microscope	O
to	O
visualize	O
immunoreactive	O
nerve	O
fibers	O
that	O
had	O
reinnervated	O
the	O
epidermis	O
and	O
the	O
sweat	O
glands	O
(	O
SG	O
).	O

For	O
analysis	O
,	O
images	O
of	O
three	O
sections	O
of	O
each	O
sample	O
were	O
collected	O
with	O
an	O
Olympus	O
DP73	O
digital	O
camera	O
,	O
the	O
number	O
of	O
intraepidermal	O
nerve	O
fibers	O
(	O
IENFs	O
)	O
was	O
counted	O
in	O
a	O
1	O
-	O
mm	O
-	O
long	O
segment	O
of	O
the	O
footpad	O
epidermis	O
and	O
the	O
number	O
of	O
reinnervated	O
SGs	O
in	O
the	O
whole	O
pad	O
was	O
also	O
quantified	O
[	O
58	O
].	O

4	O
.	O
8	O
.	O

Data	O
Analysis	O

Data	O
are	O
presented	O
as	O
mean	O
Â±	O
SEM	O
.	O

Results	O
were	O
statistically	O
analyzed	O
using	O
GraphPad	O
Prism	O
(	O
version	O
6	O
.	O
01	O
,	O
GraphPad	O
Software	O
,	O
San	O
Diego	O
,	O
CA	O
,	O
USA	O
).	O

One	O
-	O
and	O
two	O
-	O
way	O
ANOVA	O
followed	O
by	O
Bonferroni	O
â€™	O
s	O
post	O
hoc	O
test	O
for	O
comparison	O
between	O
groups	O
were	O
used	O
.	O

Statistical	O
significance	O
was	O
considered	O
when	O
p	O
-	O
value	O
was	O
<	O
0	O
.	O
05	O
.	O

5	O
.	O

Conclusions	O

In	O
conclusion	O
,	O
this	O
study	O
demonstrates	O
that	O
the	O
interaction	O
between	O
FN	B-GP
+	O
BDNF	B-GP
and	O
between	O
LM	B-GP
+	O
NGF	B-GP
/	O
NT3	B-GP
has	O
synergistic	O
effects	O
to	O
preferentially	O
enhance	O
motor	O
and	O
sensory	O
axon	O
regeneration	O
,	O
respectively	O
,	O
in	O
vitro	O
.	O

Furthermore	O
,	O
these	O
effects	O
are	O
maintained	O
in	O
vivo	O
in	O
adult	O
animals	B-OG
as	O
motor	O
and	O
sensory	O
axonal	O
regeneration	O
and	O
functional	O
recovery	O
was	O
enhanced	O
after	O
treating	O
nerve	B-DS
injuries	I-DS
with	O
a	O
nerve	O
conduit	O
prefilled	O
with	O
the	O
same	O
combinations	O
of	O
NTFs	B-GP
and	O
ECM	O
components	O
.	O

(	O
A	O
â€“	O
I	O
)	O
RT97	O
stained	O
neurites	O
from	O
spinal	O
cord	O
slices	O
cultured	O
within	O
a	O
3D	O
collagen	O
matrix	O
alone	O
,	O
and	O
with	O
addition	O
of	O
NGF	O
/	O
NT3	O
or	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
)	O
(	O
A	O
â€“	O
C	O
);	O
with	O
20	O
%	O
laminin	O
,	O
plus	O
NGF	O
/	O
NT3	O
or	O
BDNF	O
(	O
D	O
â€“	O
F	O
);	O
and	O
with	O
20	O
%	O
fibronectin	O
,	O
plus	O
NGF	O
/	O
NT3	O
or	O
BDNF	O
(	O
G	O
â€“	O
I	O
);	O
plots	O
representing	O
maximum	O
neurite	O
length	O
in	O
the	O
different	O
DRG	O
culture	O
conditions	O
(	O
J	O
);	O
quantification	O
of	O
the	O
number	O
of	O
neurites	O
grown	O
at	O
increasing	O
distance	O
from	O
the	O
DRG	O
body	O
,	O
dashed	O
line	O
represents	O
the	O
values	O
for	O
COL	O
control	O
group	O
(	O
100	O
%)	O
(	O
K	O
);	O
and	O
plots	O
of	O
the	O
quantified	O
area	O
under	O
each	O
curve	O
of	O
K	O
graph	O
(	O
L	O
).	O

Data	O
expressed	O
as	O
mean	O
Â±	O
SEM	O
.	O
*	O
p	O
<	O
0	O
.	O
05	O
and	O
***	O
p	O
<	O
0	O
.	O
001	O
.	O

(	O
A	O
â€“	O
I	O
)	O
RT97	O
stained	O
neurites	O
from	O
DRG	O
neurons	O
cultured	O
within	O
a	O
3D	O
collagen	O
matrix	O
alone	O
,	O
and	O
with	O
addition	O
of	O
NGF	O
/	O
NT3	O
or	O
BDNF	O
(	O
A	O
â€“	O
C	O
);	O
with	O
20	O
%	O
laminin	O
,	O
plus	O
NGF	O
/	O
NT3	O
or	O
BDNF	O
(	O
D	O
â€“	O
F	O
);	O
and	O
with	O
20	O
%	O
fibronectin	O
,	O
plus	O
NGF	O
/	O
NT3	O
or	O
BDNF	O
(	O
G	O
â€“	O
I	O
);	O
(	O
J	O
)	O
plots	O
representing	O
maximum	O
neurite	O
length	O
in	O
the	O
different	O
culture	O
conditions	O
,	O
dashed	O
line	O
represents	O
the	O
values	O
for	O
COL	O
control	O
group	O
(	O
100	O
%);	O
(	O
K	O
)	O
quantification	O
of	O
the	O
number	O
of	O
neurites	O
grown	O
at	O
increasing	O
distance	O
from	O
the	O
cord	O
slice	O
;	O
and	O
(	O
L	O
)	O
plots	O
of	O
the	O
quantified	O
area	O
under	O
each	O
curve	O
of	O
K	O
graph	O
.	O

Data	O
expressed	O
as	O
mean	O
Â±	O
SEM	O
.	O
*	O
p	O
<	O
0	O
.	O
05	O
,	O
**	O
p	O
<	O
0	O
.	O
01	O
and	O
***	O
p	O
<	O
0	O
.	O
001	O
.	O

(	O
A	O
â€“	O
F	O
)	O
Representative	O
micrographs	O
of	O
neurons	O
retrolabeled	O
with	O
FG	O
in	O
the	O
spinal	O
cord	O
(	O
A	O
â€“	O
C	O
);	O
and	O
DRG	O
(	O
D	O
â€“	O
F	O
)	O
of	O
rats	O
after	O
sciatic	O
nerve	O
section	O
and	O
repair	O
with	O
a	O
nerve	O
conduit	O
filled	O
:	O
with	O
COL	O
(	O
A	O
,	O
D	O
);	O
LM	O
+	O
MP	O
.	O
NGF	O
/	O
NT3	O
(	O
B	O
,	O
E	O
);	O
or	O
FN	O
+	O
MP	O
.	O
BDNF	O
(	O
C	O
,	O
F	O
).	O

(	O
G	O
â€“	O
H	O
)	O
Histogram	O
of	O
the	O
number	O
of	O
regenerated	O
motor	O
neurons	O
in	O
the	O
spinal	O
cord	O
(	O
G	O
)	O
and	O
sensory	O
neurons	O
in	O
the	O
DRG	O
(	O
H	O
)	O
in	O
the	O
short	O
term	O
(	O
20	O
days	O
after	O
injury	O
)	O
study	O
.	O

(	O
I	O
,	O
J	O
)	O
Histogram	O
of	O
the	O
number	O
of	O
regenerated	O
motor	O
neurons	O
in	O
the	O
spinal	O
cord	O
(	O
I	O
)	O
and	O
sensory	O
neurons	O
in	O
the	O
DRG	O
(	O
J	O
)	O
after	O
application	O
of	O
FG	O
retrotracer	O
at	O
the	O
ankle	O
level	O
75	O
days	O
after	O
injury	O
.	O

Data	O
expressed	O
as	O
mean	O
Â±	O
SEM	O
.	O
*	O
p	O
<	O
0	O
.	O
05	O
,	O
**	O
p	O
<	O
0	O
.	O
01	O
and	O
***	O
p	O
<	O
0	O
.	O
001	O
.	O

FN	O
+	O
MP	O
.	O
BDNF	O
and	O
LM	O
+	O
MP	O
.	O
NGF	O
/	O
NT3	O
enhance	O
motor	O
and	O
sensory	O
functional	O
recovery	O
,	O
respectively	O
.	O

(	O
A	O
,	O
B	O
)	O
Mean	O
amplitude	O
of	O
the	O
CMAP	O
in	O
TA	O
(	O
A	O
)	O
and	O
PL	O
(	O
B	O
)	O
muscles	O
during	O
follow	O
-	O
up	O
.	O
**	O
p	O
<	O
0	O
.	O
01	O
and	O
***	O
p	O
<	O
0	O
.	O
001	O
FN	O
+	O
MP	O
.	O
BDNF	O
vs	O
.	O
all	O
other	O
groups	O
referenced	O
by	O
the	O
color	O
of	O
the	O
star	O
.	O

(	O
C	O
)	O
Pinprick	O
score	O
in	O
the	O
different	O
groups	O
during	O
follow	O
-	O
up	O
;	O
*	O
p	O
<	O
0	O
.	O
05	O
.	O

(	O
D	O
)	O
Latency	O
of	O
withdrawal	O
response	O
to	O
thermal	O
stimuli	O
in	O
the	O
lateral	O
part	O
of	O
the	O
paw	O
during	O
follow	O
-	O
up	O
;	O
**	O
p	O
<	O
0	O
.	O
01	O
and	O
***	O
p	O
<	O
0	O
.	O
001	O
LM	O
+	O
MP	O
.	O
NGF	O
/	O
NT3	O
vs	O
.	O
all	O
other	O
groups	O
referenced	O
by	O
the	O
color	O
of	O
the	O
star	O
.	O

(	O
E	O
â€“	O
J	O
)	O
Representative	O
images	O
of	O
plantar	O
pads	O
immunolabeled	O
against	O
PGP	O
in	O
:	O
an	O
intact	O
rat	O
(	O
E	O
);	O
COL	O
(	O
F	O
);	O
LM	O
(	O
G	O
);	O
LM	O
+	O
MP	O
.	O
NGF	O
/	O
NT3	O
(	O
H	O
);	O
FN	O
(	O
I	O
);	O
and	O
FN	O
+	O
MP	O
.	O
BDNF	O
(	O
J	O
)	O
treated	O
animals	O
.	O

Insets	O
:	O
Detail	O
of	O
axons	O
stained	O
with	O
PGP	O
innervating	O
epidermis	O
and	O
SGs	O
.	O

(	O
K	O
,	O
L	O
)	O
Percentage	O
of	O
reinnervated	O
IENF	O
(	O
K	O
)	O
and	O
reinnervated	O
SGs	O
(	O
L	O
)	O
vs	O
.	O
intact	O
values	O
.	O
*	O
p	O
<	O
0	O
.	O
05	O
,	O
**	O
p	O
<	O
0	O
.	O
01	O
and	O
***	O
p	O
<	O
0	O
.	O
001	O
.	O

Data	O
is	O
presented	O
as	O
mean	O
Â±	O
SEM	O
.	O

Experimental	O
conditions	O
evaluated	O
in	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
studies	O
.	O

Group	O

Abbreviation	O

N	O

Description	O

In	O
Vitro	O
Condition	O

Collagen	O

COL	O

8	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O

Collagen	O
+	O
NGF	O
/	O
NT3	O

COL	O
+	O
NGF	O
/	O
NT3	O

7	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
supplemented	O
with	O
NGF	O
and	O
NT3	O
(	O
25	O
+	O
25	O
ng	O
/	O
mL	O
)	O

Collagen	O
+	O
BDNF	O

COL	O
+	O
BDNF	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
supplemented	O
with	O
BDNF	O
(	O
50	O
ng	O
/	O
mL	O
)	O

Laminin	O

LM	O

8	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
laminin	O
type	O
I	O

Laminin	O
+	O
NGF	O
/	O
NT3	O

LM	O
+	O
NGF	O
/	O
NT3	O

7	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
laminin	O
type	O
I	O
and	O
NGF	O
+	O
NT3	O
(	O
25	O
+	O
25	O
ng	O
/	O
mL	O
)	O

Laminin	O
+	O
BDNF	O

LM	O
+	O
BDNF	O

7	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
laminin	O
type	O
I	O
and	O
BDNF	O
(	O
50	O
ng	O
/	O
mL	O
)	O

Fibronectin	O

FN	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
fibronectin	O

Fibronectin	O
+	O
NGF	O
/	O
NT	O
-	O
3	O

FN	O
+	O
NGF	O
/	O
NT3	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
fibronectin	O
and	O
NGF	O
+	O
NT3	O
(	O
25	O
+	O
25	O
ng	O
/	O
mL	O
)	O

Fibronectin	O
+	O
BDNF	O

FN	O
+	O
BDNF	O

7	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
fibronectin	O
and	O
BDNF	O
(	O
50	O
ng	O
/	O
mL	O
)	O

In	O
Vivo	O
Condition	O

Collagen	O

COL	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O

Laminin	O

LM	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
laminin	O
type	O
I	O

Collagen	O
+	O
NGF	O
/	O
NT3	O
*	O

MP	O
.	O
NGF	O
/	O
NT3	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
NGF	O
+	O
NT3	O
(	O
1	O
+	O
1	O
Âµg	O
/	O
mL	O
)	O
encapsulated	O
in	O
PLGA	O
microspheres	O

Laminin	O
+	O
NGF	O
/	O
NT3	O

LM	O
+	O
MP	O
.	O
NGF	O
/	O
NT3	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
laminin	O
type	O
I	O
and	O
NGF	O
+	O
NT3	O
(	O
1	O
+	O
1	O
Âµg	O
/	O
mL	O
)	O
encapsulated	O
in	O
PLGA	O
microspheres	O

Fibronectin	O

FN	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
fibronectin	O

Collagen	O
+	O
BDNF	O
*	O

MP	O
.	O
BDNF	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
2	O
Âµg	O
/	O
mL	O
of	O
BDNF	O
encapsulated	O
in	O
PLGA	O
microspheres	O

Fibronectin	O
+	O
BDNF	O

FN	O
+	O
MP	O
.	O
BDNF	O

6	O

Collagen	O
type	O
I	O
(	O
3	O
mg	O
/	O
mL	O
)	O
gel	O
containing	O
20	O
%	O
fibronectin	O
and	O
2	O
Âµg	O
/	O
ml	O
of	O
BDNF	O
encapsulated	O
in	O
PLGA	O
microspheres	O

